Contemporary immunosuppression in renal transplantation

Area of Science:

• Nephrology
• Immunology
• Transplantation Science

Background:

• Renal allograft survival has improved due to immunosuppressive drugs.
• However, long-term graft survival is hampered by drug-induced nephrotoxicity and chronic rejection.
• Current strategies face challenges in reducing nephrotoxic calcineurin inhibitors and corticosteroids.

Purpose of the Study:

• To review advancements in immunosuppressive agents for renal transplantation.
• To discuss strategies for mitigating drug-related nephrotoxicity and chronic rejection.
• To explore novel approaches for improving long-term renal allograft survival and achieving donor-specific tolerance.

Main Methods:

• Review of current literature on immunosuppression in renal transplantation.
• Analysis of preclinical data on novel immunosuppressive agents.
• Discussion of emerging strategies for organ shortage, including xenotransplantation and bioartificial kidneys.

Main Results:

• Significant improvements in short-term renal allograft survival have been observed.
• Marginal increases in overall renal allograft half-life persist due to nephrotoxicity and chronic rejection.
• Novel agents show promise in preclinical models for reducing chronic rejection.

Conclusions:

• Development of new immunosuppressive agents is essential to reduce reliance on nephrotoxic drugs.
• Targeting specific components of the allograft response is key to overcoming chronic rejection.
• Achieving donor-specific tolerance remains the ultimate goal for successful solid organ transplantation.